Understanding Patients' Attitudes Toward Communication About the Cost of Cancer Care

Por Bullock, Andrea J., Hofstatter, Erin W., Yushak, Melinda L., Buss, Mary K.
Publicado em 2012

Palliative Oncologists: Specialists in the Science and Art of Patient Care

Por Hui, David, Finlay, Esmé, Buss, Mary K., Prommer, Eric E., Bruera, Eduardo
Publicado no J Clin Oncol (2015)

A Phase 1 trial of the PARP inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cance...

Por Liu, Joyce F., Tolaney, Sara M., Birrer, Michael, Fleming, Gini F., Buss, Mary K., Dahlberg, Suzanne E., Lee, Hang, Whalen, Christin, Tyburski, Karin, Winer, Eric, Ivy, Percy, Matulonis, Ursula A.
Publicado em 2013

CHESS Improves Cancer Caregivers’ Burden and Mood: Results of an eHealth RCT

Por DuBenske, Lori L., Gustafson, David H., Namkoong, Kang, Hawkins, Robert P., Atwood, Amy K., Brown, Roger L., Chih, Ming-Yuan, McTavish, Fiona, Carmack, Cindy L., Buss, Mary K., Govindan, Ramaswamy, Cleary, James F.
Publicado em 2013

An eHealth System Supporting Palliative Care for Patients with Nonsmall Cell Lung Cancer: A Randomized Trial

Por Gustafson, David H., DuBenske, Lori L., Namkoong, Kang, Hawkins, Robert, Chih, Ming-Yuan, Atwood, Amy K., Johnson, Roberta, Bhattacharya, Abhik, Carmack, Cindy L., Traynor, Anne M., Campbell, Toby C., Buss, Mary K., Govindan, Ramaswamy, Schiller, Joan H., Cleary, James F.
Publicado em 2013

A randomized phase 2 study of combination cediranib and olaparib versus olaparib alone as recurrence therapy in platinum-sensitive ovarian cancer

Por Liu, Joyce F., Barry, William T., Birrer, Michael, Lee, Jung-Min, Buckanovich, Ronald J., Fleming, Gini F., Rimel, BJ, Buss, Mary K., Nattam, Sreenivasa, Hurteau, Jean, Luo, Weixiu, Quy, Philippa, Whalen, Christin, Obermayer, Lisa, Lee, Hang, Winer, Eric P., Kohn, Elise C., Ivy, S. Percy, Matulonis, Ursula A.
Publicado no Lancet Oncol (2014)